Drug
Nadolol clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 1994 | 1 |
| 2000 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 5
Invion, Inc. (3) · The Hospital for Sick Children (2) · Sandoz (1) · E-DA Hospital (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · Taipei Veterans General Hospital, Taiwan (1)
Often tested with
Tested in the same studies.
Propranolol (1) · Carvedilol (1) · Isosorbide mononitrate (1) · Prazosin (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses Nadolol is read from its arms, and is right about nine times in ten.
Testing it · 9
- Nadolol for Proliferating Infantile HemangiomasCompletedPhase 2The Hospital for Sick ChildrenNCT01010308Written as Nadolol
- Nadolol Versus Propranolol in Children With Infantile HemangiomasCompletedPhase 3The Hospital for Sick ChildrenNCT02505971Written as Nadolol
- Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting ConditionsCompletedPhase 1SandozNCT00960245Written as Nadolol (1 x 80 mg) Tablets (Invamed, Inc)
- Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow ObstructionCompletedPhase 2Invion, Inc.NCT01825122Written as Nadolol
- Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild AsthmaStatus unknownPhase 2Invion, Inc.NCT01804218Written as Nadolol
- Oral Nadolol for the Treatment of Adults With Mild AsthmaCompletedPhase 1/2Invion, Inc.NCT00670267Written as nadolol
- A Trial of Nadolol Plus Isosorbide Mononitrate Versus Carvedilol for the Prevention of Variceal RebleedingCompletedPhase 4E-DA HospitalNCT01103154Written as nadolol + ISMN
- Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal RebleedingStatus unknownPhase 4Taipei Veterans General Hospital, TaiwanNCT00567216Written as Nadolol
- Secondary Prophylaxis After Variceal Bleeding in Non-RespondersCompletedPhase 4Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauNCT00450164Written as Nadolol
Given in every arm · 1 — Nadolol is usual care beside what is tested
As the comparator · 2 — what is tested is compared with Nadolol
- Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00647660Written as Corzide® Tablets 80 mg/5 mg
- Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00648297Written as Corzide® Tablets 80 mg/5 mg
Codes
What other systems call Nadolol · ClinicalTrials.gg INT007863
- MeSH (NLM) D009248NadololConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) FEN504330VNADOLOLConfirmed FDA, Wikidata
- RxNorm 7226Confirmed FDA, Wikidata
- Wikidata Q424952nadololConfirmed FDA, Wikidata
- NCI Thesaurus C29280NadololConfirmed FDA, Wikidata
- DrugBank DB01203One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D009248 | Nadolol | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | FEN504330V | NADOLOL | Confirmed FDA, Wikidata |
| RxNorm | 7226 | — | Confirmed FDA, Wikidata |
| Wikidata | Q424952 | nadolol | Confirmed FDA, Wikidata |
| NCI Thesaurus | C29280 | Nadolol | Confirmed FDA, Wikidata |
| DrugBank | DB01203 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.